Clariant AG (CLZNY)

Investigation 

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Clariant AG ("Clariant" or the "Company") (OTCMKTS: CLZNY). Investors who purchased Clariant securities are encouraged to obtain additional information and assist the investigation. 

 

The investigation concerns whether Clariant and certain of its officers and/or directors have violated federal securities laws.

 

On February 14, 2022, Clariant disclosed that it will delay issuing Q4 2021 and full year 2021 financial results due an ongoing internal investigation into potential accounting fraud.  Specifically, Clariant is investigating internal whistleblower complaints that the company has known about since September 2021, pertaining to booking issues aimed at boosting results to meet targets.  On this news, Clariant’s American Depositary Receipt (“ADR”) price fell $3.11 per ADR, or 14.55%, to close at $18.26 per ADR on February 14, 2022.

 

If you are aware of any facts relating to this investigation, or purchased Clariant shares, you can assist this investigation. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.